BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37975976)

  • 1. Synergistic properties of linezolid against Enterococcus spp. isolates: a systematic review from in vitro studies.
    Antonello RM; Riccardi N; Saderi L; Sotgiu G
    Eur J Clin Microbiol Infect Dis; 2024 Jan; 43(1):17-31. PubMed ID: 37975976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro efficacy of fosfomycin-based combinations against clinical vancomycin-resistant Enterococcus isolates.
    Tang HJ; Chen CC; Zhang CC; Su BA; Li CM; Weng TC; Chiang SR; Ko WC; Chuang YC
    Diagn Microbiol Infect Dis; 2013 Nov; 77(3):254-7. PubMed ID: 24029433
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Yadav RK; Agarwal L
    Ann Afr Med; 2022; 21(3):193-197. PubMed ID: 36204902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activities of daptomycin combined with fosfomycin or rifampin on planktonic and adherent linezolid-resistant isolates of Enterococcus faecalis.
    Zheng JX; Sun X; Lin ZW; Qi GB; Tu HP; Wu Y; Jiang SB; Chen Z; Deng QW; Qu D; Yu ZJ
    J Med Microbiol; 2019 Mar; 68(3):493-502. PubMed ID: 30882300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of daptomycin or linezolid in combination with rifampin or gentamicin against biofilm-forming Enterococcus faecalis or E. faecium in an in vitro pharmacodynamic model using simulated endocardial vegetations and an in vivo survival assay using Galleria mellonella larvae.
    Luther MK; Arvanitis M; Mylonakis E; LaPlante KL
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4612-20. PubMed ID: 24867993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment options for vancomycin-resistant enterococcal infections.
    Linden PK
    Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic activity of fosfomycin and chloramphenicol against vancomycin-resistant Enterococcus faecium (VREfm) isolates from bloodstream infections.
    Lagatolla C; Milic J; Imperi F; Cervoni M; Bressan R; Luzzati R; Di Bella S
    Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115241. PubMed ID: 33130503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of Nitrofurantoin and Fosfomycin Against Outpatient Urinary Isolates of Multidrug-Resistant Enterococci over a Period of 10 Years from India.
    Das A; Banerjee T; Anupurba S
    Microb Drug Resist; 2020 Dec; 26(12):1509-1515. PubMed ID: 31794690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tedizolid susceptibility in linezolid- and vancomycin-resistant Enterococcus faecium isolates.
    Klupp EM; Both A; Belmar Campos C; Büttner H; König C; Christopeit M; Christner M; Aepfelbacher M; Rohde H
    Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):1957-1961. PubMed ID: 27525679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk exploration and prediction model construction for linezolid-resistant Enterococcus faecalis based on big data in a province in southern China.
    Liu P; Zeng B; Wu X; Zheng F; Zhang Y; Liao X
    Eur J Clin Microbiol Infect Dis; 2024 Feb; 43(2):259-268. PubMed ID: 38032514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Epidemiology of Vancomycin-Resistant Enterococcus faecalis and Enterococcus faecium Isolated from Clinical Specimens in the Northwest of Iran.
    Jahansepas A; Ahangarzadeh Rezaee M; Hasani A; Sharifi Y; Rahnamaye Farzami M; Dolatyar A; Aghazadeh M
    Microb Drug Resist; 2018 Oct; 24(8):1165-1173. PubMed ID: 29708837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of antibiotic resistance and biofilm formation of Enterococcus species isolated from different pig farm environments in Poland.
    Grudlewska-Buda K; Skowron K; Bauza-Kaszewska J; Budzyńska A; Wiktorczyk-Kapischke N; Wilk M; Wujak M; Paluszak Z
    BMC Microbiol; 2023 Mar; 23(1):89. PubMed ID: 36997857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial activity of mupirocin, daptomycin, linezolid, quinupristin/dalfopristin and tigecycline against vancomycin-resistant enterococci (VRE) from clinical isolates in Korea (1998 and 2005).
    Lee DK; Kim Y; Park KS; Yang JW; Kim K; Ha NJ
    J Biochem Mol Biol; 2007 Nov; 40(6):881-7. PubMed ID: 18047782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
    Barber KE; Smith JR; Raut A; Rybak MJ
    J Antimicrob Chemother; 2016 Jan; 71(1):152-5. PubMed ID: 26476277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of resazurin microplate method for rapid detection of vancomycin and linezolid resistance in Enterococcus faecalis and Enterococcus faecium clinical isolates.
    Zeng W; Han Y; Zheng X; Yao Z; Xu C; Zhang X; Tang M; Shen M; Zhou T
    J Antimicrob Chemother; 2023 Feb; 78(2):466-477. PubMed ID: 36575476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activities of fosfomycin and rifampin on planktonic and adherent Enterococcus faecalis strains in an experimental foreign-body infection model.
    Oliva A; Furustrand Tafin U; Maiolo EM; Jeddari S; Bétrisey B; Trampuz A
    Antimicrob Agents Chemother; 2014; 58(3):1284-93. PubMed ID: 24145537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose Optimization of Combined Linezolid and Fosfomycin against
    Mao J; Li T; Zhang N; Wang S; Li Y; Peng Y; Liu H; Yang G; Yan Y; Jiang L; Liu Y; Li J; Huang X
    Microbiol Spectr; 2021 Dec; 9(3):e0087121. PubMed ID: 34851157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Library Screening for Synergistic Combinations of FDA-Approved Drugs and Metabolites with Vancomycin against VanA-Type Vancomycin-Resistant Enterococcus faecium.
    Gargvanshi S; Gutheil WG
    Microbiol Spectr; 2022 Oct; 10(5):e0141222. PubMed ID: 35969069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of clinical enterococci isolates, focusing on the vancomycin-resistant enterococci in a tertiary hospital in China: based on the data from 2013 to 2018.
    Zhou W; Zhou H; Sun Y; Gao S; Zhang Y; Cao X; Zhang Z; Shen H; Zhang C
    BMC Infect Dis; 2020 May; 20(1):356. PubMed ID: 32517758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged linezolid use is associated with the development of linezolid-resistant Enterococcus faecium.
    Smith TT; Tamma PD; Do TB; Dzintars KE; Zhao Y; Cosgrove SE; Avdic E
    Diagn Microbiol Infect Dis; 2018 Jun; 91(2):161-163. PubMed ID: 29496381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.